5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one

C19H24BrClN6O4 — CID 146219141

IUPAC5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one
SMILESCC[C@@H](COCCC(=O)N1CCN(c2ncc(Cl)cn2)CC1)Oc1cn[nH]c(=O)c1Br
InChIInChI=1S/C19H24BrClN6O4/c1-2-14(31-15-11-24-25-18(29)17(15)20)12-30-8-3-16(28)26-4-6-27(7-5-26)19-22-9-13(21)10-23-19/h9-11,14H,2-8,12H2,1H3,(H,25,29)/t14-/m0/s1
InChIKeySBAOXOLHBZPSCP-AWEZNQCLSA-N
MW515.80 g/mol
LogP1.89
Rot. Bonds9

About 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one

5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one (PubChem CID 146219141) has the molecular formula C19H24BrClN6O4 and a molecular weight of 515.80 g/mol. Its IUPAC name is 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one.

Molecular Properties

Compound Name5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one
PubChem CID146219141
Molecular FormulaC19H24BrClN6O4
Molecular Weight515.80 g/mol
Exact Mass514.07
IUPAC Name5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one
SMILESCC[C@@H](COCCC(=O)N1CCN(c2ncc(Cl)cn2)CC1)Oc1cn[nH]c(=O)c1Br
InChIInChI=1S/C19H24BrClN6O4/c1-2-14(31-15-11-24-25-18(29)17(15)20)12-30-8-3-16(28)26-4-6-27(7-5-26)19-22-9-13(21)10-23-19/h9-11,14H,2-8,12H2,1H3,(H,25,29)/t14-/m0/s1
InChIKeySBAOXOLHBZPSCP-AWEZNQCLSA-N
XLogP1.89
TPSA113.54 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500515.80
LogP ≤ 51.89
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one?
The IUPAC name of 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one (CID 146219141) is 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one.
What is the SMILES notation for 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one?
The canonical SMILES for 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one is CC[C@@H](COCCC(=O)N1CCN(c2ncc(Cl)cn2)CC1)Oc1cn[nH]c(=O)c1Br.
What is the InChIKey of 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one?
The InChIKey is SBAOXOLHBZPSCP-AWEZNQCLSA-N. The full InChI is InChI=1S/C19H24BrClN6O4/c1-2-14(31-15-11-24-25-18(29)17(15)20)12-30-8-3-16(28)26-4-6-27(7-5-26)19-22-9-13(21)10-23-19/h9-11,14H,2-8,12H2,1H3,(H,25,29)/t14-/m0/s1.
What are the key properties of 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one?
5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one has a molecular weight of 515.80 g/mol, XLogP of 1.89, 9 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-4-[(2S)-1-[3-[4-(5-chloropyrimidin-2-yl)piperazin-1-yl]-3-oxopropoxy]butan-2-yl]oxy-1H-pyridazin-6-one is sourced from PubChem (CID 146219141), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).